Skip to main content
Robert Soiffer, MD, Oncology, Boston, MA, Brigham and Women's Hospital

RobertJSoifferMD

Oncology Boston, MA

Hematologic Oncology

Professor of Medicine, Dana-Farber Cancer Institute

Dr. Soiffer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Soiffer's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1986 - 1989
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1983 - 1986
  • New York University School of Medicine
    New York University School of MedicineClass of 1983

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • MA State Medical License
    MA State Medical License 1986 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2010-2014
  • Boston Magazine Castle Connolly, 2009-2013
  • America's Top Doctors for Cancer Castle Connolly, 2009-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Small-Molecule BCL6 Inhibitor Effectively Treats Mice with Non-Sclerodermatous Chronic Graft-Versus-Host Disease  
    Joseph H Antin, Bruce Blazar, Leo Luznik, John Koreth, Ivan Maillard, Robert J Soiffer, James E Bradner, Jonathan S Serody, Jerome Ritz, Blood

Abstracts/Posters

  • Improved Outcomes with Cyclophosphamide/Total Body Irradiation 14 Gy Compared to Cyclophosphamide/Total Body Irradiation 12 Gy in Patients with Acute Lymphoblastic Leu...
    Robert J. Soiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Development of HHV-6-Specific Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of CD4+ T Cells
    Robert J. Soiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Feasibility and Impact of Embedded Geriatric Consultation for Frail Older Adults with Blood Cancer: A Randomized Controlled Trial
    Robert J. Soiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • BMT Peds and Adult 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Progression Risk-Based Classification of Asymptomatic Waldenström Macroglobulinemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B-Cell Lymphoma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Drug Companies Set Sights on New COVID Medicines to Boost Depleted Arsenal
    Drug Companies Set Sights on New COVID Medicines to Boost Depleted ArsenalDecember 27th, 2022
  • Discovery May Lead to Expanded Donor Pool for Stem Cell Transplants for Patients with Cancer
    Discovery May Lead to Expanded Donor Pool for Stem Cell Transplants for Patients with CancerNovember 20th, 2021
  • Miami Cancer Institute Achieves ‘Summit’ with Experts Who Share Advances in Treating Hematologic Malignancies
    Miami Cancer Institute Achieves ‘Summit’ with Experts Who Share Advances in Treating Hematologic MalignanciesMay 26th, 2021
  • Join now to see all

Grant Support

  • Immune Modulation/Hematopoietic Cell TransplantationNational Institute Of Allergy And Infectious Diseases2005–2010
  • Induction Of Anti-Tumor Immunity After Allogeneic Hematopoietic Cell TransplantNational Institute Of Allergy And Infectious Diseases2007–2009
  • Induction Of Anti-Tumor Immunity After HC TransplantNational Institute Of Allergy And Infectious Diseases2005–2006
  • Administrative &Communications CoreNational Institute Of Allergy And Infectious Diseases2005
  • T Cell Infusions After Stem Cell TransplantationNational Institute Of Allergy And Infectious Diseases2000–2002
  • Immunologic Manipulation Of Donor Marrow PRE And Post Allogeneic BMTNational Institute Of Allergy And Infectious Diseases1996–1998

Hospital Affiliations